Julia Liang

Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex

Julia Liang, Eleni Pitsillou, Chris Karagiannis et al. · Computational Biology and Chemistry · 2020 · 69 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay

Eleni Pitsillou, Julia Liang, Katherine Ververis et al. · Frontiers in Chemistry · 2020 · 62 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

OliveNet™: a comprehensive library of compounds from<i>Olea europaea</i>

Natalie P. Bonvino, Julia Liang, Elizabeth D McCord et al. · Database · 2018 · 60 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +10

Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay

Eleni Pitsillou, Julia Liang, Chris Karagiannis et al. · Computational Biology and Chemistry · 2020 · 60 citations · Full text

Pharmacy, Infectious Diseases, Molecular Biology +15

Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface

Julia Liang, Chris Karagiannis, Eleni Pitsillou et al. · Computational Biology and Chemistry · 2020 · 45 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15